Most Recent
Clayton Utz's public statements referencing its terms of engagement with AMP in drafting an independent report are irrelevant if it knew the document was destined for the corporate regulator, legal experts say, and transcripts from the Royal Commission suggest the law firm did know.
Warner Bros. has won an appeal in a dispute with the Australian director and producer of Hollywood smash Mad Max: Fury Road over a $7 million bonus the Sydney-based film makers claimed they were owed after making the film under budget.
The Australian Securities and Investments Commission has lost its appeal in a case against a former Australian Wheat Board senior executive over an alleged kickback scam in relation to the United Nation's Oil-for-Food programme.
Class action firm Slater & Gordon is preparing an investor class action against logistics company Brambles over alleged misstatements about revenue and sales growth for the 2017 financial year.
Facing demands for answers and a call to be suspended from government contract work, Clayton Utz has finally spoken out over its role in the scandal embroiling AMP.
US-based online gaming giant Valve Corp. has lost its bid to appeal to the High Court of Australia a $3 million judgment for misleading customers who bought faulty products online.
Calling on the competition chief to "have another look" at AGL's decision to shutter its Liddell plant, Liberal MP Craig Kelly says the power company's conduct makes for a clear case under the new misuse of market power provision of Australia's competition law.
The corporate regulator has confirmed it is investigating AMP over its 'fees for no service' practice revealed at the Hayne Royal Commission in stunning testimony Treasurer Scott Morrison on Wednesday called "deeply disturbing".
A judge has dismissed a second defamation case against Fairfax Media brought by an associate of a murdered Sydney businessman, ruling the plaintiff waived his right to sue again after dropping an earlier suit against the publisher for a $75,000 payout.
A judge has dismissed a bid by Geneva Laboratories to add the sole director of a healthcare product distributor as a defendant in a high-stakes case over counterfeit versions of its popular and premium-priced Bio-Oil line of skin-care products.